FDA Broadly Supports Oragenics’ Pre-IND Development Program for Its SARS-CoV-2 Vaccine
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced receipt of feedback to its Type B Pre-IND Meeting Request from the U.S. Food and Drug Administration (FDA) that it is in broad agreement with the company’s […]
TearClear Appoints Robert Bailey to Board of Directors
UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, a global ophthalmic pharmaceutical company, announces the appointment of industry veteran Robert Bailey to the company’s Board of Directors. Mr. Bailey brings over two decades of leadership experience in the Ophthalmology industry having served on the executive teams as General Counsel/Chief Legal Officer for […]
The Key to Farming on Mars Might Be Breeding Parasitic Space Worms
The parasitic space worms are coming, and they’re ready to kill. No, it’s not the tagline for some Tremors in Space B-movie monster flick. Instead, it’s the result of some research recently published in the journal npj Microgravity by UF Innovate | The Hub and UF Innovate | Sid Martin Biotech alum Pheronym, an Ag-biotech pest control company. And despite how it […]
Using HSV Helper Viruses to Increase AAV Production
Recognizing the industry-wide need to improve adeno-associated virus (AAV) vector manufacturing, UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), has adopted changes intended to increase yield and purity. Some AAV manufacturing processes use adherent cells grown in stacked trays. AGTC sees that model as a barrier to scaling, pointing to the […]
RTI Surgical Receives 510(k) Clearance for Dynamic Active Compression (DAC) Plate
UF startup and UF Innovate | Sid Martin Biotech alum RTI Surgical Holdings, Inc., a global surgical implant company, recently received 510(k) Clearance from the U.S. Food and Drug Administration (FDA) for the Dynamic Active Compression (DAC) Plate to provide stabilization and fixation of small bones of the foot. The DAC plate addresses an unmet need in […]
Dr. Sadasivan Vidyasagar, Associate Professor at University of Florida, and entrinsic bioscience CEO Stephen Gatto, Receive University of Florida’s ‘Invention of the Year 2020’ Award
UF Innovate | Sid Martin Biotech resident client entrinsic bioscience (EBS), a company pioneering a next-generation protein modulation technology, announced that its co-founder, Dr. Sadasivan (Sagar) Vidyasagar, an associate professor at the University of Florida, and entrinsic bioscience’s CEO, Stephen Gatto, received the “Invention of the Year 2020” Award from UF Innovate | Tech Licensing for their novel amino-acid […]
UF’s Sid Martin Biotech Business Incubator Celebrates 25 Years
As one of the first biotech business incubators in the United States, UF Innovate | Sid Martin Biotech has paved the way to success for many startup companies. Sid Martin celebrates its 25th anniversary today and continues to have a timeless impact. “The 25th anniversary of Sid Martin is a testimonial to business incubation – […]
CEOs Discuss Sid Martin Biotech’s Impact on Their Business Success
For the past 25 years, UF Innovate | Sid Martin Biotech has provided the foundation that has turned many startup companies into successful businesses. For many CEOs, Sid Martin played a fundamental role in keeping their companies alive during their infant stages. Gary Ascani is a former CEO of Banyan Biomarkers, Inc., a biotechnology company […]
entrinsic bioscience Strengthens Leadership Team with Appointment of Mario Wanderley as Chief Financial Officer and Accelerates Product Development with New Research Facility
UF startup and UF Innovate | Sid Martin Biotech resident client entrinsic bioscience (EBS), a company pioneering a next-generation protein modulation technology, announced the appointment of Mario Wanderleyas Chief Financial Officer. Mr. Wanderley brings 23 years of financial, operational, and strategic expertise to EBS, with significant experience in the medical device, technology, software, telecommunications, and […]
Customized Gene Therapies Successfully Target Rare Eye Diseases
Can gene therapies be effective for the treatment of rare genetic diseases? One company may have found a solution that incorporates a high degree of customization, manufacturing expertise, and years’ worth of knowledge. Having been with Applied Genetic Technologies Corporation (AGTC) for almost 20 years, CEO Sue Washer has first-hand experience in seeing novel ideas […]